|
Re: The waiting game.....
|
5
|
Resverlogix Corp.
|
Jan 15, 2019 11:18AM
|
|
Re: AHA late breaking abstract
|
5
|
Resverlogix Corp.
|
Nov 11, 2019 07:17AM
|
|
One year after REDUCE-IT's 2018 AHA presentation
|
5
|
Resverlogix Corp.
|
Nov 11, 2019 07:34AM
|
|
Re: A fair and optimistic write up on BETonMACE
|
5
|
Resverlogix Corp.
|
Nov 24, 2019 06:15PM
|
|
Re: News on Amgen's collesteral drug, Repatha; poor sales / resistant payer uptake
|
5
|
Resverlogix Corp.
|
Apr 26, 2017 08:14PM
|
|
Re: Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
5
|
Resverlogix Corp.
|
Aug 05, 2017 11:42AM
|
|
Re: Apabetalone for non diabetics or normal cholesterol?
|
5
|
Resverlogix Corp.
|
Dec 10, 2019 01:05PM
|
|
Re: Will Stock Price languish for some time to come?
|
5
|
Resverlogix Corp.
|
Jan 26, 2016 04:59PM
|
|
ACC abstracts are out
|
5
|
Resverlogix Corp.
|
Mar 06, 2017 10:57PM
|
|
Re: Zenith Efficacy Data - When?
|
5
|
Zenith Epigenetics
|
Jun 26, 2016 06:42AM
|
|
Re: Top scientific things that indicate that BETonMACE will be successful
|
5
|
Resverlogix Corp.
|
Feb 08, 2019 12:17PM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
5
|
Zenith Epigenetics
|
Mar 10, 2016 02:38PM
|
|
Re: Resverlogix Closes Extension of Maturity Date of Loan and Announces Private Placement
|
5
|
Resverlogix Corp.
|
Sep 05, 2017 10:44AM
|
|
Re: Pan versus Selective Inhibitors....I need analogies
|
5
|
Resverlogix Corp.
|
Nov 22, 2017 01:50PM
|
|
No show at Rodman and Renshaw?
|
5
|
Resverlogix Corp.
|
Sep 11, 2017 02:51PM
|
|
Re: Just curious...
|
5
|
Resverlogix Corp.
|
May 23, 2019 03:19PM
|
|
Re: Almost show time.....
|
5
|
Resverlogix Corp.
|
Mar 04, 2016 09:12AM
|
|
What happens when the database is locked?
|
5
|
Resverlogix Corp.
|
Sep 01, 2019 02:47PM
|
|
Re: Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 08:49AM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
5
|
Zenith Epigenetics
|
Jul 25, 2019 02:50PM
|
